# ABCL (AbCellera Biologics Inc.) - SEC EDGAR Financial Statements

> AbCellera Biologics Inc. reported $67.86M in revenue and a net loss of $148.3M for the trailing twelve months ended September 30, 2026 (up 18.8% year over year), with a -298.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/ABCL
- Markdown: https://convexityos.com/fundamentals/ABCL.md
- SEC CIK: 0001703057
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001703057&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $67.86M | +18.8% YoY |
| Operating Income | TTM | -$202.2M | -298.0% margin |
| Net Income | TTM | -$148.3M | -218.5% net margin |
| Diluted EPS | TTM | -$0.47 | Split-adjusted |
| Free Cash Flow | TTM | -$32.85M | -48.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $163.8M | Total debt: $133.8M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $75.13M | $28.83M | $38.02M | $485.4M | $375.2M | $233.2M | $11.61M |
| Research & Development | $186.8M | $167.3M | $175.7M | $107.9M | $62.06M | $29.39M | $10.11M |
| Selling, General & Admin | -- | $98.27M | $89.36M | $66.75M | $48.76M | $15.75M | $4.01M |
| Total Operating Expenses | $292.2M | $343.6M | $275.2M | $268.9M | $170.8M | $77.12M | $15.73M |
| **Operating Income** | -$217.1M | -$314.8M | -$237.2M | $216.5M | $204.4M | $156.0M | -$4.12M |
| **EBITDA** | -$195.0M | -$287.9M | -$212.8M | $244.4M | $218.9M | $160.9M | -$2.51M |
| Interest Income | $28.33M | $38.47M | $42.25M | $16.08M | $3.33M | $293K | $155K |
| Income Before Tax | -$177.6M | -$200.4M | -$174.0M | $239.1M | $219.1M | $157.8M | -$2.21M |
| Income Tax Expense | -$31.18M | -$37.54M | -$27.63M | $80.58M | $65.69M | $38.91M | -- |
| **Net Income** | -$146.4M | -$162.9M | -$146.4M | $158.5M | $153.5M | $118.9M | -$2.21M |
| Basic EPS | -$0.49 | -$0.55 | -$0.51 | $0.56 | $0.56 | $0.53 | -$0.01 |
| **Diluted EPS** | -$0.49 | -$0.55 | -$0.51 | $0.50 | $0.48 | $0.45 | -$0.01 |
| Basic Shares Outstanding | 298.7M | 294.3M | 289.2M | 285.1M | 275.8M | 159.2M | 151.3M |
| Diluted Shares Outstanding | 298.7M | 294.3M | 289.2M | 314.8M | 318.3M | 263.1M | 151.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10.64M | $4.05M | $8.31M | $44.85M | $8.96M | $17.08M | $4.24M | $5.05M |
| Research & Development | $43.53M | $45.99M | $46.66M | $50.09M | $55.03M | $39.21M | $42.50M | $46.08M |
| Selling, General & Admin | $13.61M | $13.85M | $12.33M | -- | $24.96M | $21.99M | $19.07M | $31.94M |
| Total Operating Expenses | $63.95M | $66.83M | $65.83M | $73.44M | $85.23M | $66.67M | $66.89M | $77.81M |
| **Operating Income** | -$53.31M | -$62.78M | -$57.52M | -$28.58M | -$76.28M | -$49.59M | -$62.66M | -$72.75M |
| **EBITDA** | -$46.51M | -$55.79M | -$50.68M | -$22.49M | -$71.03M | -$44.12M | -$57.33M | -$124.2M |
| Interest Income | -- | -- | $3.64M | $5.92M | $6.76M | $7.59M | $5.52M | $8.67M |
| Income Before Tax | -$42.81M | -$58.97M | -$49.54M | -$19.50M | -$68.77M | -$36.34M | -$52.98M | -$46.83M |
| Income Tax Expense | -$2.05M | -$3.54M | -$6.37M | -$10.55M | -$11.65M | -$1.62M | -$7.36M | -$12.62M |
| **Net Income** | -$40.76M | -$55.43M | -$43.16M | -$8.95M | -$57.12M | -$34.73M | -$45.62M | -$34.21M |
| Basic EPS | -$0.13 | -$0.18 | -$0.14 | -- | -$0.19 | -$0.12 | -$0.15 | -- |
| **Diluted EPS** | -$0.13 | -$0.18 | -$0.14 | -- | -$0.19 | -$0.12 | -$0.15 | -- |
| Basic Shares Outstanding | 318.1M | 305.6M | 303.1M | -- | 298.9M | 298.5M | 297.7M | -- |
| Diluted Shares Outstanding | 318.1M | 305.6M | 303.1M | -- | 298.9M | 298.5M | 297.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $128.5M | $156.3M | $133.3M | $386.5M | $476.1M | $594.1M |
| **Cash & Short-Term Investments** | $533.8M | $625.6M | $760.6M | $386.5M | $476.1M | $594.1M |
| Accounts Receivable, Net | $39.41M | $31.98M | $0 | -- | -- | $903K |
| Inventory | $6.34M | $0 | -- | -- | -- | -- |
| Other Current Assets | $111.1M | $67.14M | $55.81M | $75.41M | $21.25M | $5.97M |
| **Total Current Assets** | $728.2M | $751.4M | $872.0M | $1.03B | $929.8M | $813.3M |
| Property, Plant & Equipment, Net | -- | -- | -- | $217.3M | $111.6M | $17.92M |
| Goodwill | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M | $31.50M |
| Intangible Assets | $38.38M | $42.11M | $120.4M | $131.5M | $148.4M | $115.2M |
| Other Non-Current Assets | $51.95M | $96.54M | $94.24M | $46.33M | $30.64M | $8.39M |
| **Total Non-Current Assets** | $628.7M | $609.2M | $616.1M | $515.4M | $388.8M | $192.2M |
| **Total Assets** | $1.36B | $1.36B | $1.49B | $1.54B | $1.32B | $1.01B |
| Short-Term Debt | -- | -- | -- | -- | -- | $190K |
| Deferred Revenue (Current) | $13.53M | $13.52M | $18.96M | $21.61M | $7.54M | $6.59M |
| **Total Current Liabilities** | $64.31M | $76.61M | $119.0M | $118.3M | $120.7M | $103.5M |
| Deferred Revenue (Non-Current) | $3.50M | $5.70M | $8.20M | $19.52M | $27.41M | -- |
| Other Non-Current Liabilities | $10.38M | $7.17M | $5.91M | $3.09M | $1.73M | $6.62M |
| **Total Non-Current Liabilities** | $325.7M | $227.9M | $216.8M | $189.3M | $172.2M | $71.54M |
| **Total Liabilities** | $390.0M | $304.5M | $335.8M | $307.6M | $292.8M | $175.0M |
| **Total Debt (incl. Leases)** | $143.2M | $65.36M | $77.38M | $82.26M | $40.06M | $4.58M |
| Common Stock | $802.3M | $777.2M | $753.2M | $734.4M | $722.4M | $710.4M |
| Retained Earnings | -$29.48M | $116.9M | $279.8M | $426.2M | $267.7M | $114.2M |
| Accumulated Other Comp. Income | -$4.23M | -$4.38M | -$1.72M | -$1.39M | $280K | -- |
| **Total Stockholders' Equity** | $966.9M | $1.06B | $1.15B | $1.23B | $1.03B | $830.5M |
| Total Equity | $966.9M | $1.06B | $1.15B | $1.23B | $1.03B | $830.5M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $163.8M | $120.1M | $77.06M | $128.5M | $83.16M | $92.44M | $159.3M | $156.3M |
| **Cash & Short-Term Investments** | $764.4M | $540.1M | $504.7M | $533.8M | $495.7M | $553.1M | $605.3M | $625.6M |
| Accounts Receivable, Net | $38.29M | $38.42M | $39.16M | $39.41M | $71.25M | $70.00M | $63.61M | $31.98M |
| Inventory | $7.57M | $7.58M | $7.86M | $6.34M | -- | -- | -- | $0 |
| Other Current Assets | $68.77M | $95.53M | $98.10M | $111.1M | $133.0M | $116.8M | $94.71M | $67.14M |
| **Total Current Assets** | $876.2M | $679.2M | $664.6M | $728.2M | $695.1M | $742.1M | $765.0M | $751.4M |
| Goodwill | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M |
| Intangible Assets | $38.39M | $36.53M | $37.46M | $38.38M | $39.32M | $40.26M | $41.19M | $42.11M |
| Other Non-Current Assets | $63.62M | $62.10M | $69.14M | $51.95M | $53.07M | $57.45M | $61.56M | $96.54M |
| **Total Non-Current Assets** | $623.7M | $628.3M | $642.5M | $628.7M | $660.9M | $659.9M | $579.2M | $609.2M |
| **Total Assets** | $1.50B | $1.31B | $1.31B | $1.36B | $1.36B | $1.40B | $1.34B | $1.36B |
| Deferred Revenue (Current) | $35.04M | $20.70M | $7.74M | $13.53M | $15.69M | $16.95M | $18.79M | $13.52M |
| **Total Current Liabilities** | $70.47M | $53.19M | $47.29M | $64.31M | $68.80M | $67.02M | $75.40M | $76.61M |
| Deferred Revenue (Non-Current) | $48.05M | $40.45M | -- | $3.50M | $5.85M | $11.63M | $13.75M | $5.70M |
| Other Non-Current Liabilities | $10.44M | $9.71M | $11.32M | $10.38M | $1.39M | $1.56M | $1.62M | $7.17M |
| **Total Non-Current Liabilities** | $366.9M | $358.4M | $321.7M | $325.7M | $323.1M | $328.0M | $245.8M | $227.9M |
| **Total Liabilities** | $437.4M | $411.6M | $369.0M | $390.0M | $392.0M | $395.0M | $321.2M | $304.5M |
| **Total Debt (incl. Leases)** | $133.8M | $135.6M | $140.2M | $143.2M | $142.2M | $142.1M | $67.85M | $65.36M |
| Common Stock | $996.2M | $821.2M | $816.5M | $802.3M | $794.5M | $791.7M | $790.1M | $777.2M |
| Retained Earnings | -$168.8M | -$128.1M | -$72.65M | -$29.48M | -$20.54M | $36.58M | $71.31M | $116.9M |
| Accumulated Other Comp. Income | -$3.42M | -$3.15M | -$2.42M | -$4.23M | -$2.70M | -$2.66M | -$7.00M | -$4.38M |
| **Total Stockholders' Equity** | $1.06B | $896.0M | $938.1M | $966.9M | $964.0M | $1.01B | $1.02B | $1.06B |
| Total Equity | $1.06B | $896.0M | $938.1M | $966.9M | $964.0M | $1.01B | $1.02B | $1.06B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$146.4M | -$162.9M | -$146.4M | $158.5M | $153.5M | $118.9M | -$2.21M |
| Depreciation & Amortization | $22.14M | $26.84M | $24.39M | $27.84M | $14.45M | $4.84M | $1.60M |
| Stock-Based Compensation | $55.79M | $67.58M | $64.18M | $49.48M | $30.65M | $8.40M | $890K |
| Change in Receivables | -$55.62M | -$75.12M | -$45.93M | -$22.71M | -$37.39M | -$5.47M | -$1.80M |
| **Operating Cash Flow** | -$131.3M | -$108.6M | -$43.88M | $277.4M | $244.6M | $22.69M | $2.69M |
| Capital Expenditure | -$42.77M | -$78.40M | -$76.95M | -$70.66M | -$58.45M | -$9.67M | -$4.00M |
| **Free Cash Flow** | -$174.1M | -$187.0M | -$120.8M | $206.7M | $186.1M | $13.02M | -$1.30M |
| Acquisitions, Net | -- | -- | $0 | $0 | -$11.46M | -$87.64M | -- |
| Purchases of Investments | -$436.0M | -$765.1M | -$1.02B | -$764.0M | -$274.7M | -- | -- |
| **Investing Cash Flow** | $87.75M | $121.4M | -$221.1M | -$352.6M | -$332.2M | -$119.8M | -$5.78M |
| Common Stock Issued | -- | -- | -- | -- | -- | $522.8M | -- |
| **Financing Cash Flow** | $14.08M | $12.77M | $10.36M | -$1.63M | -$3.89M | $683.7M | $195K |
| **Net Change in Cash** | -$28.37M | $23.00M | -$254.0M | -$86.49M | -$92.97M | $586.6M | -$2.89M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$40.76M | -$55.43M | -$43.16M | -$8.95M | -$57.12M | -$34.73M | -$45.62M | -$34.21M |
| Depreciation & Amortization | $6.81M | $6.99M | $6.84M | $6.09M | $5.25M | $5.47M | $5.33M | -$51.45M |
| Stock-Based Compensation | $11.67M | $12.29M | $12.01M | $12.90M | $13.89M | $14.21M | $14.79M | $15.23M |
| Change in Receivables | -- | -- | $13.10M | -$39.67M | -$3.43M | -$11.39M | -$1.13M | -$20.86M |
| **Operating Cash Flow** | $26.91M | $25.92M | -$33.52M | -$34.74M | -$52.59M | -$32.40M | -$11.55M | -$8.00M |
| Capital Expenditure | -$1.61M | -$2.13M | -$3.83M | -$9.84M | -$8.93M | -$13.37M | -$10.64M | -$15.63M |
| **Free Cash Flow** | $25.30M | $23.79M | -$37.35M | -$44.59M | -$61.52M | -$45.77M | -$22.19M | -$23.63M |
| Purchases of Investments | -$316.7M | -$141.9M | -$166.3M | -$111.3M | -$33.16M | -$126.6M | -$165.0M | -$152.8M |
| **Investing Cash Flow** | -$183.4M | $11.34M | -$25.08M | $75.14M | $36.49M | -$31.81M | $7.93M | $35.70M |
| **Financing Cash Flow** | $200.6M | $6.39M | $7.19M | $4.12M | $7.37M | -$3.38M | $5.97M | $4.14M |
| **Net Change in Cash** | $43.73M | $43.23M | -$51.45M | $44.80M | -$9.28M | -$66.83M | $2.94M | $29.68M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -289.0% | -1091.7% | -623.8% | 44.6% | 54.5% | 66.9% | -35.5% |
| **Net Profit Margin** | -194.9% | -564.8% | -385.0% | 32.7% | 40.9% | 51.0% | -19.0% |
| Return on Equity (ROE) | -15.1% | -15.4% | -12.7% | 12.9% | 15.0% | 14.3% | -- |
| Return on Assets (ROA) | -10.8% | -12.0% | -9.8% | 10.3% | 11.6% | 11.8% | -- |
| Current Ratio | 11.32x | 9.81x | 7.33x | 8.67x | 7.70x | 7.86x | -- |
| Quick Ratio | 11.23x | 9.81x | 6.39x | 3.27x | 3.95x | 5.75x | -- |
| Debt to Equity | 0.15x | 0.06x | 0.07x | 0.07x | 0.04x | 0.01x | -- |
| **Revenue Growth (YoY)** | +160.6% | -24.2% | -92.2% | +29.4% | +60.9% | +1907.9% | -- |
| Operating Income Growth (YoY) | -- | -- | -209.6% | +5.9% | +31.0% | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -192.4% | +3.3% | +29.1% | -- | -- |
| EPS Growth (YoY) | -- | -- | -191.1% | 0.0% | +5.7% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -115.8% | +13.4% | +977.9% | +742.2% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -158.5% | +11.1% | +1329.9% | -- | -- |
| 5Y Revenue / Share Growth | -82.8% | +27.7% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -165.6% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -298.0% | -340.3% | -267.6% | -289.0% | -739.7% | -847.6% | -1395.3% | -1091.6% |
| **Net Profit Margin** | -218.5% | -248.8% | -181.7% | -194.9% | -486.0% | -503.9% | -726.2% | -564.8% |
| Return on Equity (ROE) | -14.0% | -18.4% | -15.3% | -15.1% | -17.8% | -16.5% | -16.4% | -15.4% |
| Return on Assets (ROA) | -9.9% | -12.6% | -11.0% | -10.8% | -12.7% | -11.8% | -12.5% | -12.0% |
| Current Ratio | 12.43x | 12.77x | 14.05x | 11.32x | 10.10x | 11.07x | 10.15x | 9.81x |
| Quick Ratio | 12.33x | 12.63x | 13.89x | 11.23x | 8.24x | 9.30x | 8.87x | 9.81x |
| Debt to Equity | 0.13x | 0.15x | 0.15x | 0.15x | 0.15x | 0.14x | 0.07x | 0.06x |
| **Revenue Growth (YoY)** | +18.8% | -76.3% | +96.3% | +788.2% | +37.6% | +133.3% | -57.5% | -45.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
